Earnings per Share and Stock Plans (Tables)

12 Months Ended

Mar. 31, 2026

The following table sets forth the computation of basic and diluted earnings per share (share data presented in thousands):


	Year Ended March 31,
Numerator for basic and diluted earnings per share:	2026		2025		2024


Net income (loss) attributable to the Company	$	(229,535)	$	(5,138)	$	46,625
Net income (loss) attributable to preferred stockholders	(17,050)		—		—
Net income (loss) attributable to common stockholders	$	(212,485)	$	(5,138)	$	46,625

Denominators:
Weighted-average common stock outstanding— denominator for basic EPS	28,714		28,738		28,728

Effect of dilutive employee stock options, RSU's and performance shares	—		—		298

Adjusted weighted-average common stock outstanding and assumed conversions— denominator for diluted EPS	28,714		28,738		29,026

A summary of option transactions during each of the three fiscal years in the period ended March 31, 2026, is as follows:


	Shares	Weighted- average Exercise Price per share		Weighted- average Remaining Contractual Life (in years)	Aggregate Intrinsic Value
Outstanding at April 1, 2023	975,171	$	34.54	7.13	$	5,497
Granted	298,674	36.19
Exercised	(62,060)	25.73
Cancelled	(17,945)	37.49
Outstanding at March 31, 2024	1,193,840	$	35.37	6.93	$	12,392
Granted	188,089	45.34
Exercised	(12,648)	29.44
Cancelled	(115,655)	41.26
Outstanding at March 31, 2025	1,253,626	$	36.38	5.99	$	80
Granted	413,549	17.59
Exercised	(1,951)	15.16
Cancelled	(60,273)	29.68
Outstanding at March 31, 2026	1,604,951	31.82		6.12	$	—
Exercisable at March 31, 2026	995,139	$	35.61	4.68	$	—

The following table provides certain information with respect to stock options outstanding at March 31, 2026:


	Stock Options Outstanding	Weighted-average Exercise Price		Weighted-average Remaining Contractual Life
Range of Exercise Prices

$10.01 to 20.00	449,677	$	17.32	8.09
$20.01 to 30.00	130,581	$	25.11	2.79
$30.01 to $40.00	713,910	$	34.61	5.39
$40.01 to $50.00	175,033	$	45.49	7.68
$50.01 to $60.00	135,750	$	54.26	4.60
	1,604,951	$	31.82	6.12

The following table provides certain information with respect to stock options exercisable at March 31, 2026:


Range of Exercise Prices	Stock Options Exercisable	Weighted- average Exercise Price per share

$10.01 to 20.00	50,006	$	15.16
$20.01 to 30.00	130,581	25.11
$30.01 to $40.00	616,226	34.36
$40.01 to $50.00	62,741	45.75
$50.01 to $60.00	135,585	54.26
	995,139	$	35.61

The following table provides the weighted-average assumptions used to value stock options granted during fiscal 2026, 2025, and 2024:

A summary of the restricted stock unit awards granted under the Company’s LTIP plan as of March 31, 2026 is as follows:


	Shares	Weighted-average Grant Date Fair Value per share
Unvested at April 1, 2023	247,225	$	37.02
Granted	159,816	37.57
Vested	(145,862)	39.21
Forfeited	(10,267)	41.61
Unvested at March 31, 2024	250,912	$	35.91
Granted	136,870	39.71
Vested	(127,514)	38.60
Forfeited	(12,632)	40.56
Unvested at March 31, 2025	247,636	$	36.38
Granted	479,911	18.05
Vested	(134,639)	30.77
Forfeited	(32,361)	22.88
Unvested at March 31, 2026	560,547	$	22.82

A summary of the performance shares transactions during each of the three fiscal years in the period ended March 31, 2026 is as follows:


	Shares	Weighted-average Grant Date Fair Value per share
Unvested at April 1, 2023	179,005	$	34.39
Granted	73,453	36.58
Vested	(39,720)	35.95
Forfeited	(33,838)	28.66
Unvested at March 31, 2024	178,900	$	36.13
Granted	123,401	37.44
Vested	(19,960)	53.56
Forfeited	(27,485)	50.02
Unvested at March 31, 2025	254,856	$	33.90
Granted	235,711	17.88
Vested	(40,592)	17.68
Forfeited	(23,533)	33.03
Unvested at March 31, 2026	426,442	$	26.64